戻る Agenda
Session 4: Pharmacovigilance - Continued Collaboration Between the UK and Europe
Session Chair(s)
Vicki Edwards, RPh
Vice President, Pharmacovigilance Excellence and International QPPV
Abbvie, United Kingdom
This session will review issues related to pharmacovigilance, for Day 1 and looking forward. This will summarise what we know, what we still don’t know and what we have to do to be prepared.
Speaker(s)
Wearing Both Hats: PRAC and UK Vigilance Post-Brexit
Mick Foy
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Director of Delivery
Industry Case Example: Day One Practical Considerations
Vicki Edwards, RPh
Abbvie, United Kingdom
Vice President, Pharmacovigilance Excellence and International QPPV